Published : Apr-2020
No. of Pages : 133
1.1 List of Figures
1.2 List of Tables
2 Executive Summary
2.1 Executive Summary
2.2 Key Highlights
2.3 Key Events: Russian Pharmaceutical News, 2014-2020
2.4 Key Events: Russian Pharmaceutical Market
2.5 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.6 Key Events: Mergers and Acquisitions
2.7 Country Profile, Russia, 2019
3 Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Pharma 2020
3.3 Pharmaceutical Market - Exports
3.4 Pharmaceutical Market - Imports
3.5 Pharmaceutical Supply Channels, Russia
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, Russia
3.7 COVID-19 Epidemiology, Russia
3.8 COVID-19 Impact and Developments in Healthcare Market, Russia
3.9 Pharmaceutical Market - Major Players
4 Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Device Market - Major Segments
4.3 Medical Device Market - Major Players
5 Pharmaceutical and Medical Device Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6 Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, Russia 2019-2020
6.2 Deal Analysis: Medical Devices, Russia 2019-2020
7 HealthTech Landscape
7.1 HealthTech Landscape
7.2 Digital Health Companies, Russia
7.3 Key HealthTech Deals, Russia
7.4 Telemedicine Regulations, Russia
7.5 HealthTech Landscape- Russia- Benefits and Risks
8 Market Access
8.1 Overview of Healthcare System, Russia
8.2 Reimbursement Process, Russia
8.3 Overview of Health Insurance, Russia
8.4 Healthcare Spending and Health Price Index, Russia
8.5 Pricing Policies, Russia
8.6 Regulatory Landscape, Russia
8.6.1 Market Authorization for Pharmaceutical Drugs, Russia
8.6.2 Regulatory Reforms, Russia
8.6.3 Market Authorization for Medical Devices, Russia
8.6.4 Licensing Process for Pharmaceutical Exports and Imports
8.6.5 Intellectual Property Rights, Patent, Russia
8.6.5 Clinical Trial Regulations, Russia
8.6.6 Pharmaceutical Clinical Trials Landscape, Russia
8.6.7 Pharmaceutical Advertising Regulations, Russia
8.6.8 Labeling Regulations, Russia
9 Country Healthcare Landscape
9.1 Healthcare Initiatives
9.2 Healthcare Facilities, Russia
9.3 Healthcare Parameters, Russia
9.4 Life Expectancy and Immunization Rate, Russia
9.5 Environmental Health, Russia
9.6 Healthcare Personnel, Russia
9.7 Disease Burden, Russia
9.8 Healthcare Expenditure
10 Trade Associations, Russia
11 Trade Fairs, Russia
12 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.1.4 Expert Panel
13.2 Bibliography
13.3 Contact Us
13.4 Disclaimer
List of Tables
Table 1: Major Pharmaceutical Distributors, Russia, 2018
Table 2: Sales Structure of RTU drugs by ATC groups, Russia, 2018
Table 3: COVID-19 Indicators (Number of cases), Global and Russia, 2020
Table 4: COVID-19 Clinical Trials, Russia, 2020
Table 5: COVID-19 Test Kits, Russia, 2020
Table 6: Orthopedic Devices Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 7: Ophthalmic Devices Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 8: Diagnostic Imaging Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 9: Cardiovascular Devices Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 10: In Vitro Diagnostics Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 11: Out-Patient Drug Reimbursement Eligibility, Russia, 2019
Table 12: Medical Equipment Risk Classification, Russia, 2019
Table 13: Patent Fees, Russia, 2019
Table 14: Trade Fairs, 2020
List of Figures
Figure 1: Pharmaceutical Market, Russia, Revenue ($B), 2012-2018
Figure 2: Medical Device Market, Russia, Revenue ($B), 2015-2020
Figure 3: Country Profile, Russia, 2019
Figure 4: Pharmaceutical Market, Russia, Revenue (RUB B and $B), 2012-2018
Figure 5: Pharmaceutical Market, Russia, Revenue Forecast (RUB B and $B), 2019-2025
Figure 6: Pharma 2020, Russia, 2020
Figure 7: Pharmaceutical Exports ($M), Russia, 2010-2019
Figure 8: Top Export Partners, Russia, 2019
Figure 9: Pharmaceutical Imports ($B), Russia, 2010-2019
Figure 10: Top Import Partners, Russia, 2019
Figure 11: OTC Market, Russia, Major Category (%), 2019
Figure 12: OTC Market, Russia, Revenue ($M), 2013-2020
Figure 13: COVID-19 (Number of cases), Russia, 2020
Figure 14: COVID-19 (Number of deaths), Russia, 2020
Figure 15: Pharmaceutical Market, Major Players, 2018
Figure 16: Medical Device Market, Russia, Revenue ($B), 2015-2020
Figure 17: Medical Device Market, Russia, Revenue Forecast ($B), 2021-2025
Figure 18: Medical Devices Market, Major Segments (%), Russia, 2019
Figure 19: Orthopedic Devices Market, Russia, Revenue ($M), 2015-2022
Figure 20: Orthopedic Devices Market, Russia, Market Share of Major Players (%), 2019
Figure 21: Ophthalmic Devices Market, Russia, Revenue ($M), 2015-2022
Figure 22: Ophthalmic Devices Market, Russia, Market Share of Major Players (%), 2015
Figure 23: Diagnostic Imaging Market, Russia, Revenue ($M), 2015-2022
Figure 24: Diagnostic Imaging Market, Russia, Market Share of Major Players (%), 2015
Figure 25: Cardiovascular Devices Market, Russia, Revenue ($M), 2015-2022
Figure 26: Cardiovascular Devices Market, Russia, Market Share of Major Players (%), 2018
Figure 27: In Vitro Diagnostics Market, Russia, Revenue ($M), 2015-2022
Figure 28: In Vitro Diagnostics Market, Russia, Market Share of Major Players (%), 2015
Figure 29: Diagnostic Market, Russia, Revenue ($M), 2015-2020
Figure 30: Diagnostic Market, Russia, Revenue ($M), 2021-2025
Figure 31: Medical Device Market, Russia, Revenue ($B) of Major Companies, 2017
Figure 32: Deal Value and Deal Count, Pharmaceutical Market, Russia, 2019-2020
Figure 33: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Russia, 2019-2020
Figure 34: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Russia, 2019-2020
Figure 35: Top Therapy Areas by Deal Value, Pharmaceutical Market, Russia, 2019-2020
Figure 36: Top Therapy Areas by Deal Number, Pharmaceutical Market, Russia, 2019-2020
Figure 37: M&A Deals by Therapy Area, Pharmaceutical Market, Russia, 2019-2020 (by value and by number)
Figure 38: Deal Value and Deal Count, Medical Devices, Russia, 2019-2020
Figure 39: Deal Value and Deal Count Quarterly, Medical Devices, Russia, 2019-2020
Figure 40: Overview of Healthcare System, Russia, 2019
Figure 41: Public Provision of Pharmaceuticals, Russia, 2019
Figure 42: Government Health Insurance (% of population), Russia, 2010-2018
Figure 43: Out-of-Pocket Expenditure ($ per capita), Russia, 2010-2017
Figure 44: Health Price Index (% change), Russia, 2011-2019
Figure 45: Drug price regulation, Russia, 2019
Figure 46: Filing Procedure for Registration of Maximum Selling Price for EDL Drugs, Russia, 2019
Figure 47: Roszdravnadzor, Organization Chart, 2020
Figure 48: Rospotrebnadzor, Organization Chart, 2020
Figure 49: Drug Approval Process, Russia, 2019
Figure 50: Drug Approval Overall Process, Russia, 2019
Figure 51: Rospatent Organization Structure, Russia, 2019
Figure 52: Patent Application Process, Russia, 2019
Figure 53: Pharmaceutical Clinical Trials Count By Trial Status, Russia, 2018-2019
Figure 54: Pharmaceutical Clinical Trials Count By Phase, Russia, 2018-2019
Figure 55: Pharmaceutical Clinical Trials Count By Therapy Area, Russia, 2018-2019
